TG Therapeutics Inc
Ownership
Ownership Structure
Who owns TG Therapeutics Inc (TGTX)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.4% of the shares are freely tradable; institutional investors hold 70.2%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 14.41 | 22,050,045 | -0.9 | 06/30/2026 |
| Vanguard Portfolio Management, LLC | 5.20 | 7,963,266 | -3.8 | 06/30/2026 |
| State Street Corp | 5.09 | 7,786,471 | -10.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.02 | 6,149,403 | -6.9 | 06/30/2026 |
| Geode Capital Management, LLC | 2.38 | 3,642,216 | +4.1 | 06/30/2026 |
| D. E. Shaw & Co LP | 2.22 | 3,400,808 | +476.4 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.52 | 8,449,942 | +0.0 | 09/30/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.87 | 4,398,279 | +0.3 | 09/30/2026 |
| iShares Russell 2000 ETF | 2.46 | 3,765,888 | -1.1 | 09/30/2026 |
| Vanguard Small Cap Index | 2.02 | 3,099,443 | -2.2 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Charney Laurence N | Director | 168,640 | 10,320,768 $ | Sep 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Charney Laurence N | Director | Sell | 5,000 | 54.96 | 274,800 |
| Aug 7, 2026 | Charney Laurence N | Director | Other | 450 | 0.00 | – |
| Aug 7, 2026 | Charney Laurence N | Director | Other | 500 | 0.00 | – |
| Aug 6, 2026 | Charney Laurence N | Director | Other | 5,100 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.